Company intelligence / Profile preview

Kylane Laboratoires

Plan-les-Ouates, Geneva, Switzerlandkylane.com ↗

Ownership: Private
Development stage: Other

Overview

Kylane Laboratoires has developed clinically validated injectable hyaluronic acid fillers for facial and body aesthetic treatments. Their proprietary technologies, Oxifree and Rheopure, enable high safety profiles and improved volumizing effects with natural tissue integration. The company’s first products are on the market for use by healthcare professionals such as dermatologists and plastic surgeons.

Therapeutic areas: DermatologyEndocrinology
Modalities: BiologicHyaluronic acid-based therapy (Hydrogel-based drug delivery therapy)Injectable medical device (for aesthetic use)
Industry: Implantable Medical Devices

Partnerships

Collaborations with leading clinicians/medical doctors in dermatology/plastic surgery/aesthetics

Beyond the preview

Go deeper on Kylane Laboratoires.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kylane Laboratoires.

Explore the full profile